Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Embrex
Yahoo Beta:0.88

Company Description:  Embrex, Inc. is a biotechnology company that specializes in delivering vaccines to chickens still in the egg. The company makes machines for delivering vaccines and for culling dead eggs, and also produces some of the vaccines administered in ovo. The product is used on about 85% of domestic chicken eggs.

Purchase Date:04 Feb 2004 Sale Date:17 Feb 2005
Purchase Price:$13.30 Sale Price:$11.00
  --Split Adjusted:$13.30  --Split Adjusted:$11.00
Shares Purchased:400 Shares Sold:400
  --Split Adjusted:400  --Split Adjusted:400
Transaction Fee:$130.26 Transaction Fee:$115.72
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$14.74 High$0.00
Date28 Jan 2004 Date01 Jan 1996
Low$9.81 Low$0.00
Date07 Aug 2003 Date01 Jan 1996
S&P (Purchase Date):$1,129.42 S&P (Sale Date):$1,200.75

Timing:  The price has risen steadily over the last six months, although the price has dropped about a dollar in the last 10 days.
Reason:  As a small cap company with growth potential, this company fits our new investment profile. In contrast to many biotech companies, Embrex is profitable. Our valuation suggests the company is significantly undervalued.

Reason:  Embrex has not made the sales targest we hoped for at the time of our investment.

S&P Gain: 6.32 % Annualized Gain: 6.66%
Stock Gain: -17.29 % Annualized Gain: -18.1%

Net Holding Return ($): $-1,165.98
Net Holding Return (%): -21.39 %